TapImmune Inc. (OTCMKTS:TPIV) Gets Severely Corrected
tags: TPIV
TapImmune Inc. (OTCMKTS:TPIV) hasn’t had that great of a chart performance in this year so far. The ticker has lost quite a lot of value and it often gets neglected by investors, despite the attempts to boost investor confidence through optimistic press releases.
The company’s market cap has already dropped below $30 million, which isn’t that much for an entity that has some decent financials. Here is a quick look at some of the numbers of prime interest contained in TPIV’s report for the first quarter of the year.
- cash: $6.57 million
- current assets: $6.64 million
- current liabilities: $28 million
- revenues: ZERO
- loss from operations: $6.15 million
Meanwhile, the company hadn’t issued any new press releases for nearly a month now. This might be the reason for yesterday’s crash, that saw TPIV lose 13.68% of its value and close at $0.41, while a total of 691 thousand traded shares generated $298 thousand in daily dollar volume.
The intraday chart shows us that most of the trading happened in the second half of the session, after TPIV took a dive, which suggests that some long-term investors might have decided to go out while their losses are limited.
Still, TPIV is much more stable in today’s session and it doesn’t seem like the slide will gather any momentum. That, however, doesn’t mean that you should skip doing your due diligence and weighing out the risks before putting any money on the line.
